XPhyto Therapeutics Corp. (OTCMKTS:XPHYF – Get Rating) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totalling 2,000 shares, an increase of 33.3% from the June 30th total of 1,500 shares. Based on an average daily trading volume, of 1,600 shares, the days-to-cover ratio is presently 1.3 days.
XPhyto Therapeutics Price Performance
Shares of OTCMKTS XPHYF opened at $0.35 on Monday. The business's 50 day moving average price is $0.47 and its two-hundred day moving average price is $0.70. The company has a market cap of $28.14 million, a PE ratio of -1.51 and a beta of -0.20. The company has a quick ratio of 0.42, a current ratio of 0.55 and a debt-to-equity ratio of 1.34. XPhyto Therapeutics has a twelve month low of $0.27 and a twelve month high of $1.60.
Get XPhyto Therapeutics alerts:About XPhyto Therapeutics
(Get Rating)
XPhyto Therapeutics Corp. operates as a bioscience company in Germany and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, such as depression, anxiety, addiction, and trauma-related stress disorder.See Also
- Get a free copy of the StockNews.com research report on XPhyto Therapeutics (XPHYF)
- Use These To Find Your Stock's Support and Resistance Levels
- Is Boeing Stock is Ready for Lift-Off ?
- Elon Musk is Out, But Should You Be In Twitter Stock?
- 3 Earnings Announcements That Could Surprise
- Twitter's Up For Third Week In A Row: What's Next For The Stock?
Receive News & Ratings for XPhyto Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XPhyto Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.